Peter Stierli

Peter Stierli is the communications responsible for Siegfried, a Swiss pharmaceutical contract manufacturer and supplier based in Zofingen. With nearly a century of experience in the industry, Siegfried has established a strong presence in the United States, operating multiple production facilities. Stierli has recently been in the news discussing the impact of proposed 100% import tariffs on original medications by former President Donald Trump, highlighting that Siegfried is minimally affected due to its significant local production capabilities in the U.S.